These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 5038112)

  • 1. The malabsorption associated with chronic liver disease in children.
    Weber A; Roy CC
    Pediatrics; 1972 Jul; 50(1):73-83. PubMed ID: 5038112
    [No Abstract]   [Full Text] [Related]  

  • 2. Fats and bile salts. II. Pathologic considerations.
    Holt PR
    J Am Diet Assoc; 1972 Jun; 60(6):495-8. PubMed ID: 4556785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nutrition of children with steatorrhea using fats of medium-chain fattty acids].
    Kühni M
    Schweiz Med Wochenschr; 1968 May; 98(20):755-9. PubMed ID: 5701058
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Cholestyramine therapy in cholestatic liver disease of children.
    Nelson R; Murphy GM; Edkins S; Nutter S; Anderson CM
    Gut; 1974 Oct; 15(10):825. PubMed ID: 4434934
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of chologenic diarrhea and steatorrhea in the enteral bile acid losing syndrome using cholestyramine and medium-chain triglycerides].
    Sickinger K
    Dtsch Med Wochenschr; 1969 May; 94(22):1151-7. PubMed ID: 5768540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of the bile in the etiology of malabsorption in patients with chronic liver diseases].
    Solis Herruzo JA
    Rev Clin Esp; 1972 May; 125(4):301-12. PubMed ID: 5080173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Steatorrhea: pathophysiological, diagnostic and therapeutic aspects with special reference to the newest findings on the metabolism of bile acids].
    Schentke KU
    Z Arztl Fortbild (Jena); 1975 Mar; 69(5):225-9. PubMed ID: 58489
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of medium-chain triglycerides in the management of biliary atresia.
    Cohen MI; Gartner LM
    J Pediatr; 1971 Sep; 79(3):379-84. PubMed ID: 5567960
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medium chain triglycerides in the treatment of malabsorption disorders].
    Johansson C; Moberg S; Nilsson LH
    Nord Med; 1969 Jul; 82(30):921-5. PubMed ID: 5808583
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholestyramine therapy in a patient with hypoplasia of the intrahepatic bile ducts].
    Ijssel de Schepper JJ; van Gelderen HH
    Maandschr Kindergeneeskd; 1969 Sep; 37(3):65-73. PubMed ID: 5345121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Absence of intrahepatic bile ducts. A case].
    Hambourg M; Leveque B; Desbois JC; Mande R
    Ann Pediatr (Paris); 1971 Nov; 18(11):695-702. PubMed ID: 5142280
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts.
    Sharp HL; Carey JB; White JG; Krivit W
    J Pediatr; 1967 Nov; 71(5):723-36. PubMed ID: 6054760
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum lipids and fecal steroids in patients with celiac disease: effects of gluten-free diet and cholestyramine.
    Vuoristo M; Tarpila S; Miettinen TA
    Gastroenterology; 1980 Jun; 78(6):1518-25. PubMed ID: 7372070
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medium-chain fats in dietetic treatment of some disorders of the digestive tract].
    Foltyn H; Korzon M
    Pol Tyg Lek; 1972 Jul; 27(31):1207-10. PubMed ID: 4561156
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenesis, diagnosis and treatment of maldigestion.
    Wildgrube HJ; Siede W
    Acta Hepatogastroenterol (Stuttg); 1974 Apr; 21(2):151-60. PubMed ID: 4615549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Undirected liver biopsy in children].
    Cihula J; Vortel V; Herout V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1971; 14(1):1-125. PubMed ID: 4327988
    [No Abstract]   [Full Text] [Related]  

  • 17. Bile acid metabolism in patients with cirrhosis. I. Kinetic aspects of cholic acid metabolism.
    Vlahcevic ZR; Buhac I; Farrar JT; Bell CC; Swell L
    Gastroenterology; 1971 Apr; 60(4):491-8. PubMed ID: 5554239
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the efficiency of bile salt recirculation in patients with terminal ileopathies by means of deoxycholate determination in duodenal aspirates.
    Thaysen EH; Bruusgaard A; Eriksen B
    Scand J Gastroenterol; 1970; 5(1):39-47. PubMed ID: 5429865
    [No Abstract]   [Full Text] [Related]  

  • 19. The inflammatory and atresia-inducing disease of the liver and bile ducts.
    Pérez-Soler A
    Monogr Paediatr; 1976; 8():1-245. PubMed ID: 1004513
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.
    Hofmann AF; Poley JR
    Gastroenterology; 1972 May; 62(5):918-34. PubMed ID: 5029077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.